Congress

14:00 - 14:20
MS Database in Central America

FERNANDO DE GRACIA

Speaker

14:20 - 14:25
Discussion

14:25 - 14:45
Strategies for defining the distribution and clinical caractheristcs os Latin America

JUAN IGNACIO ROJAS

Speaker

14:45 - 14:50
Discussion

14:50 - 15:10
The Experience with Brando: The Brazilian MS database

GIORDANI RODRIGUES DOS PASSOS

PORTO ALEGRE / RS Speaker

15:10 - 15:15
Discussion

15:15 - 15:35
Neuromyelitis Optica Registry - NMO-RG: A program for Latin America

DENISON ALVES PEDROSA

SAO PAULO / SP Speaker

15:35 - 15:40
Discussion

16:10 - 16:30
Clinical trials of disease-modifying agents in pediatric Multiple Sclerosis

SILVIA TENEMBAUM

Speaker

16:30 - 16:35
Discussion

16:35 - 16:55
The gut microbiome in pediatric-onset MS

HELEN TREMLETT

Speaker

16:55 - 17:00
Discussion

17:00 - 17:20
Treatment of pediatric aquaporin-4 antibody-positive NMOSD

RENATA PAOLILO

SAO PAULO / SP Speaker

17:20 - 17:25
Discussion

17:25 - 17:45
Treatment of MOG-IgG associated disease in paediatric patients

BRUNA KLEIN

PORTO ALEGRE / RS Speaker

17:45 - 17:50
Discussion

18:00 - 18:25
Progressão de doença na EM

HERVAL RIBEIRO SOARES NETO

SÃO PAULO / SP Speaker

18:25 - 18:50
Discussão de Casos Clínicos

ANA CLAUDIA PICCOLO

SAO PAULO / SP Speaker

18:50 - 19:00
Considerações finais

PAULO PEREIRA CHRISTO

BELO HORIZONTE / MG Speaker

19:00 - 19:10
Neurology

RAFAEL PATERNO CASTELLO DIAS CARNEIRO

SAO PAULO / SP Competitor

GIORDANI RODRIGUES DOS PASSOS

PORTO ALEGRE / RS Competitor

MILENA SALES PITOMBEIRA

FORTALEZA / CE Competitor

EULDES MENDES JUNIOR

MONTES CLAROS / MG Competitor

ANA BEATRIZ AYROZA GALVAO RIBEIRO GOMES

Competitor

LAURA PAROLIN

BLUMENAU / SC Competitor

SIMONE ABRANTE LUCATTO

VILHENA / RO Competitor

JOAO MARCOS CAMPOS FERREIRA

NITEROI / RJ Competitor

19:10 - 19:20
Pediatrics

BRUNA KLEIN

PORTO ALEGRE / RS Competitor

INGRID LACERDA

SAO PAULO / SP Competitor

19:20 - 19:30
Immune/basic

VINICIUS BOLDRINI

CAMPINAS / SP Competitor

LAURA PAROLIN

BLUMENAU / SC Competitor

NATALIA MUNHOZ ALVES

CAMPINAS / SP Competitor

19:30 - 19:40
Radiology

DIEGO FRAGOSO

SAO PAULO / SP Competitor

RANGEL DE SOUSA COSTA

RIO DE JANEIRO / RJ Chairman

08:00 - 08:25
PACTRIMS and research of MS and related diseases in Asia

KAZUO FUJIHARA

Speaker

08:25 - 08:30
Discussion

08:30 - 08:55
Advances in MOGAD diagnosis

DOUGLAS KAZUTOSHI SATO

PORTO ALEGRE / RS Speaker

08:55 - 09:00
Discussion

09:00 - 09:25
Update of the ECTRIMS/EAN DMT guideline

MARIA PIA AMATO

Speaker

09:25 - 09:30
Discussion

09:30 - 09:55
Future Revisions of the McDonald Diagnostic Criteria for MS

JEFFREY COHEN

Speaker

09:55 - 10:00
Discussion

10:00 - 10:25
Epidemiology of MS in Latin America

FERNANDO DE GRACIA

Speaker

10:25 - 10:30
Discussion

10:30 - 11:00
Floodlight MS: tecnologia e ciência aliados para ver além da superfície da vivência com a esclerose múltipla

GUILHERME SCIASCIA DO OLIVAL

SAO PAULO / SP Palestrante

11:00 - 11:45
Cognitive impairment in MS: latest developments

MARIA PIA AMATO

Speaker

11:45 - 12:00
Discussion

13:00 - 13:30
Conscientização da doença

JEFFERSON BECKER

PORTO ALEGRE / RS Speaker

13:30 - 14:00
Novas terapias - Inebilizumabe

MICHAEL LEVY

Speaker

14:00 - 14:20
Is it time for Cognitive Rehabilitation to become standard of care?

JOHN DELUCA

Speaker

14:20 - 14:25
Discussion

14:25 - 14:45
Update on Natural History of MS

FERNANDO FARIA ANDRADE FIGUEIRA

RIO DE JANEIRO / RJ Speaker

14:45 - 14:50
Discussion

14:50 - 15:10
Moving toward Big Data in MS: what have we learned so far

GAVIN GIOVANNONI

Speaker

15:10 - 15:15
Discussion

15:15 - 15:25
Platform 01 - Analysis of the microvesicle from CSF of Multiple Sclerosis untreated patients and patients treated with Fingolimod

15:25 - 15:30
Discussion

15:30 - 15:40
Platform 02 - Improved detection of demyelinating lesions in multiple sclerosis using Phase-Sensitive Inversion Recovery (PSIR) to Double Inversion Recovery (DIR) signal ratio

15:40 - 15:45
Discussion

16:15 - 16:35
Unmet needs in MS Treatment

JEFFERSON BECKER

PORTO ALEGRE / RS Speaker

16:35 - 16:40
Discussion

16:40 - 17:00
The MS prodrome

HELEN TREMLETT

Speaker

17:00 - 17:05
Discussion

17:05 - 17:25
Fatigue: Can we measure it and can we treat it?

JOHN DELUCA

Speaker

17:25 - 17:30
Discussion

17:30 - 17:40
Platform 03 - Dimethyl Fumarate increases gradually anti-inflammatory molecules in the intestinal mucosa of C57BL/6 with EAE

17:40 - 17:45
Discussion

17:45 - 17:55
Platform 04 - Longitudinal changes in juxtacortical lesion burden in multiple sclerosis are associated with early hippocampal atrophy

17:55 - 18:00
Discussion

19:00 - 19:10
Comparison of Multiple Sclerosis’ management by neuroimmunologists, general neurologists, and young neurologists.

19:10 - 19:20
Rhythmic transcranial magnetic stimulation (rTMS) for fatigue in people with multiple sclerosis

19:20 - 19:30
The spectrum of the opening symptoms of demyelinating diseases of the central nervous system. A study of 955 patients

19:30 - 19:40
“Stable” vs. “silent progressive multiple sclerosis”: a real-world retrospective clinical imaging Brazilian study

19:40 - 19:50
Lymphopenia in multiple sclerosis patients treated with dimethyl fumarate (DMF)

19:50 - 20:00
Corpus Callosum Index: 15 years of a Brazilian Tool for Multiple Sclerosis Follow Up

08:00 - 10:00
Discussion

GAVIN GIOVANNONI

Debater

GIANCARLO COMI

Debater

NASRIN ASGARI

Debater

10:30 - 10:50
Paradigm shift in DMT: From escalation to early high efficacy treatment algorithms

HANS-PETER HARTUNG

Speaker

10:50 - 10:55
Discussion

10:55 - 11:15
Progressive Multiple Sclerosis: when to treat and when not to treat

GIANCARLO COMI

Speaker

11:15 - 11:20
Discussion

11:20 - 11:40
Lessons from clinical trial failures – moving forward with innovative trial designs

LUDWIG KAPPOS

Speaker

11:40 - 11:45
Discussion

11:45 - 12:05
Will be Epstein Barr an appropriate target to treat multiple sclerosis

GAVIN GIOVANNONI

Speaker

12:05 - 12:10
Discussion

12:10 - 12:30
What is new in MS rehabilitation

LETIZIA LEOCANI

Speaker

12:30 - 12:35
Discussion

14:35 - 14:55
What comes next to double serum negative NMOSD?

KAZUO FUJIHARA

Speaker

14:55 - 15:00
Discussion

15:00 - 15:20
Management of NMOSD and MOG-AD attacks

MARCELO MATIELLO

Speaker

15:20 - 15:25
Discussion

15:25 - 15:45
How helpful is CSF analysis in NMOSD differential diagnosis?

NASRIN ASGARI

Speaker

15:45 - 15:50
Discussion

15:50 - 16:10
The clinical spectrum of atypical optic neuritis

MARCO LANA-PEIXOTO

BELO HORIZONTE / MG Speaker

16:10 - 16:15
Discussion

16:15 - 16:25
Platform - NMOSD 1 - Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD

16:25 - 16:30
Discussion

16:30 - 16:40
Platform - NMOSD 2 - ADEM, para-infectious and post-vaccination optic neuritis. Analysis of a large cohort.

16:40 - 16:45
Discussion

17:15 - 17:35
Disability in MOGAD: Predictive factors?

DOUGLAS KAZUTOSHI SATO

PORTO ALEGRE / RS Speaker

17:35 - 17:40
Discussion

17:40 - 18:00
OCT in CNS demyelinating diseases: An update

FRIEDEMANN PAUL

Speaker

18:00 - 18:05
Discussion

18:05 - 18:30
NMOSD, new approaches and unmet needs

ANA BEATRIZ AYROZA GALVAO RIBEIRO GOMES

Speaker

18:30 - 18:35
Discussion

18:35 - 18:45
Platform - NMOSD 3 - Risk and characteristics of vaccine associated relapse in patients with neuromyelitis optica spectrum disorders: a systematic review and meta-analysis

18:45 - 18:50
Discussion

18:50 - 19:00
Platform - NMOSD 4 - Frequency of typical and atypical forms of optic neuritis at onset of demyelinating diseases of the central nervous system.

19:00 - 19:05
Discussion

08:00 - 08:20
Electrophysiology versus OCT in the differential diagnosis of CNS demyelinating diseases

LETIZIA LEOCANI

Speaker

08:20 - 08:25
Discussion

08:25 - 08:45
Distinguishing papilledema from pseudopapilledema

MARCO LANA-PEIXOTO

BELO HORIZONTE / MG Speaker

08:45 - 08:50
Discussion

08:50 - 09:10
The natural history of Leber’s hereditary optic neuropathy

CARLOS FILIPE CASTILHO C. CHICANI

SAO PAULO / SP Speaker

09:10 - 09:15
Discussion

09:15 - 09:35
Infectious optic neuritis and neuroretinitis

MARIO TERUO SATO

CURITIBA / PR Speaker

09:35 - 09:40
Discussion

10:40 - 11:00
MRI markers of progression in MS

HANS-PETER HARTUNG

Speaker

11:00 - 11:05
Discussion

11:05 - 11:25
MRI in Aq4Ab x MOGAD

CAROLINA DE MEDEIROS RIMKUS

SAO PAULO / SP Speaker

11:25 - 11:30
Discussion

11:30 - 11:50
MS mimics: MRI in Systemic Inflammatory Disorders

FERNANDA CRISTINA RUEDA LOPES

RIO DE JANEIRO / RJ Speaker

11:50 - 11:55
Discussion

11:55 - 12:15
MS and Adem in children

SILVIA TENEMBAUM

Speaker

12:15 - 12:20
Discussion

12:20 - 12:40
Short case reports with MRI correlations

ANTONIO JOSE DA ROCHA

SAO PAULO / SP Speaker

12:40 - 12:45
Discussion

12:45 - 13:05
Short case reports with MRI correlations

FERNANDO FARIA ANDRADE FIGUEIRA

RIO DE JANEIRO / RJ Speaker

13:05 - 13:10
Discussion

13:05 - 13:10
Short case reports with MRI correlations